France's BioProtein Technologies, a biotechnology company
specialising in the production of therapeutic proteins in the milk
of transgenic rabbits, has extended its biomanufacturing services
to include recombinant vaccine production.
Pall tells BIOPHEX/INTERPHEX conference that use of its
ultrafiltration technologies cuts both the time and cost of
conjugate vaccine production; greater adoption could increase the
availability of vaccines for diseases such as meningitis...
A team of researchers at Switzerland's Novartis and Rigel
Pharmaceuticals in the USA have created a method for discovering
molecules that are involved in signalling pathways, according to a
report in the Journal of Biology.
US biopharmaceutical company Aastrom Biosciences has received
approval to market and sell its DCV-II cancer vaccine production
kits in the European Union. The company believes the market will
offer a new potential path to near-term...
Danish biotech company Symphogen has obtained a European patent on
its Symphage technology for the development of antibody-based
drugs. Clinical trials of the product candidate are due to start in
US company PPD is taking a stake in Chemokine Therapeutics, a
Canadian- and US-based biotechnology company, to continue
development of a proprietary peptide derived from a particular
chemokine that may make the peptide useful as a...